1. Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study. (18th October 2018) Authors: Yoshino, T; Portnoy, D C; Obermannová, R; Bodoky, G; Prausová, J; Garcia-Carbonero, R; Ciuleanu, T; García-Alfonso, P; Cohn, A L; Van Cutsem, E; Yamazaki, K; Lonardi, S; Muro, K; Kim, T W; Yamaguchi, K; Grothey, A; O'Connor, J; Taieb, J; Wijayawardana, S R; Hozak, R R Journal: Annals of oncology Issue: Volume 30:Number 1(2019) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗